Valuation: MINDESTA

Market Cap 34.05L 29.16L 27.2L 24.96L 46.9L 33Cr 47.83L 3.23Cr 1.26Cr 16Cr 1.28Cr 1.25Cr 54Cr P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 34.09L 29.19L 27.23L 24.99L 46.95L 33Cr 47.88L 3.23Cr 1.26Cr 16Cr 1.28Cr 1.25Cr 54Cr EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+4.48%+3.67%+25.09% 5.12TCr
-0.26%+3.69%+479.00%+607.13% 4.54TCr
+1.96%+8.11%+19.65%+91.55% 4.2TCr
-0.25%+8.59%+38.62%+19.89% 4.21TCr
0.00%-3.91%+18.49%+47.98% 3.19TCr
-0.18%+2.90% - - 1.67TCr
-0.14%+5.85%+35.08%+148.94% 1.71TCr
-0.82%+2.56%+6.24%+34.38% 1.48TCr
-0.40%+4.07%+88.59%+45.06% 1.39TCr
Average +0.07%+3.24%+86.17%+127.50% 3.06TCr
Weighted average by Cap. +0.26%+3.18%+104.06%+149.87%

Financials

2024 2025
Net sales - -
Net income -3L -2L -2L -2L -3L -2.39Cr -4L -23.71L -9L -1.2Cr -9L -9L -3.97Cr -2L -1L -1L -1L -2L -1.49Cr -2L -14.78L -6L -74.76L -6L -6L -2.48Cr
Net Debt 16.82T 14.4T 13.44T 12.33T 23.17T 16.09L 23.62T 2L 62.13T 8L 63.15T 61.78T 26.7L 3.46T 2.96T 2.76T 2.53T 4.76T 3L 4.85T 32.74T 12.76T 2L 12.97T 12.69T 5L
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-